Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of atrial natriuretic factor in the dog

R. S. Zimmerman, J. A. Schirger, Brooks Sayre Edwards, T. R. Schwab, D. M. Heublein, John C Jr. Burnett

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Infusion of α-human-atrial natriuretic factor (α-h-ANF) into pentobarbitol anesthesized dogs (n = 10) at 0.0025, 0.005, 0.01, and 0.3 μg/kg/min was performed to differentiate the physiologic actions of atrial natriuretic factor from its pharmacologic actions. The lowest doses of atrial natriuretic factor infusion resulted in circulating levels that were previously produced by 0-10% saline volume expansion. At the lowest infusion rate, circulating ANF increased 31 ± 3 pg/ml, resulting in a significant increase in absolute sodium excretion, fractional excretion of sodium, and fractional excretion of lithium, and a significant decrease in urine osmolality. A greater change in circulating atrial natriuretic factor (96 ± 12 pg/ml) was required to significantly decrease right atrial pressure, cardiac output, and plasma renin activity, and to increase systemic vascular resistance and total and fractional excretion of potassium. The highest dose of atrial natriuretic factor infused was required to decrease arterial pressure and renal vascular resistance. The present study demonstrates that 1) atrial natriuretic factor is natriuretic and diuretic at physiologic concentrations; 2) at low concentrations, atrial natriuretic factor appears to decrease the whole kidney proximal tubular reabsorption of sodium and does not affect glomerular filtration rate; 3) a greater (but physiologic) change in circulating atrial natriuretic factor is required to significantly decrease cardiac output, cardiac filling pressure, and plasma renin activity than is required to significantly increase sodium excretion; and 4) a decrease in systemic atrial pressure and vascular resistance does not occur at physiologic concentrations of atrial natriuretic factor.

Original languageEnglish (US)
Pages (from-to)63-69
Number of pages7
JournalCirculation Research
Volume61
Issue number1
StatePublished - 1987

Fingerprint

Atrial Natriuretic Factor
Dogs
Kidney
Sodium
Vascular Resistance
Atrial Pressure
Renin
Cardiac Output
Pharmacologic Actions
Glomerular Filtration Rate
Lithium
Diuretics
Osmolar Concentration
Potassium
Arterial Pressure
Urine
Pressure

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of atrial natriuretic factor in the dog. / Zimmerman, R. S.; Schirger, J. A.; Edwards, Brooks Sayre; Schwab, T. R.; Heublein, D. M.; Burnett, John C Jr.

In: Circulation Research, Vol. 61, No. 1, 1987, p. 63-69.

Research output: Contribution to journalArticle

@article{fccb98d37b0340d5aea8668104d990bb,
title = "Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of atrial natriuretic factor in the dog",
abstract = "Infusion of α-human-atrial natriuretic factor (α-h-ANF) into pentobarbitol anesthesized dogs (n = 10) at 0.0025, 0.005, 0.01, and 0.3 μg/kg/min was performed to differentiate the physiologic actions of atrial natriuretic factor from its pharmacologic actions. The lowest doses of atrial natriuretic factor infusion resulted in circulating levels that were previously produced by 0-10{\%} saline volume expansion. At the lowest infusion rate, circulating ANF increased 31 ± 3 pg/ml, resulting in a significant increase in absolute sodium excretion, fractional excretion of sodium, and fractional excretion of lithium, and a significant decrease in urine osmolality. A greater change in circulating atrial natriuretic factor (96 ± 12 pg/ml) was required to significantly decrease right atrial pressure, cardiac output, and plasma renin activity, and to increase systemic vascular resistance and total and fractional excretion of potassium. The highest dose of atrial natriuretic factor infused was required to decrease arterial pressure and renal vascular resistance. The present study demonstrates that 1) atrial natriuretic factor is natriuretic and diuretic at physiologic concentrations; 2) at low concentrations, atrial natriuretic factor appears to decrease the whole kidney proximal tubular reabsorption of sodium and does not affect glomerular filtration rate; 3) a greater (but physiologic) change in circulating atrial natriuretic factor is required to significantly decrease cardiac output, cardiac filling pressure, and plasma renin activity than is required to significantly increase sodium excretion; and 4) a decrease in systemic atrial pressure and vascular resistance does not occur at physiologic concentrations of atrial natriuretic factor.",
author = "Zimmerman, {R. S.} and Schirger, {J. A.} and Edwards, {Brooks Sayre} and Schwab, {T. R.} and Heublein, {D. M.} and Burnett, {John C Jr.}",
year = "1987",
language = "English (US)",
volume = "61",
pages = "63--69",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of atrial natriuretic factor in the dog

AU - Zimmerman, R. S.

AU - Schirger, J. A.

AU - Edwards, Brooks Sayre

AU - Schwab, T. R.

AU - Heublein, D. M.

AU - Burnett, John C Jr.

PY - 1987

Y1 - 1987

N2 - Infusion of α-human-atrial natriuretic factor (α-h-ANF) into pentobarbitol anesthesized dogs (n = 10) at 0.0025, 0.005, 0.01, and 0.3 μg/kg/min was performed to differentiate the physiologic actions of atrial natriuretic factor from its pharmacologic actions. The lowest doses of atrial natriuretic factor infusion resulted in circulating levels that were previously produced by 0-10% saline volume expansion. At the lowest infusion rate, circulating ANF increased 31 ± 3 pg/ml, resulting in a significant increase in absolute sodium excretion, fractional excretion of sodium, and fractional excretion of lithium, and a significant decrease in urine osmolality. A greater change in circulating atrial natriuretic factor (96 ± 12 pg/ml) was required to significantly decrease right atrial pressure, cardiac output, and plasma renin activity, and to increase systemic vascular resistance and total and fractional excretion of potassium. The highest dose of atrial natriuretic factor infused was required to decrease arterial pressure and renal vascular resistance. The present study demonstrates that 1) atrial natriuretic factor is natriuretic and diuretic at physiologic concentrations; 2) at low concentrations, atrial natriuretic factor appears to decrease the whole kidney proximal tubular reabsorption of sodium and does not affect glomerular filtration rate; 3) a greater (but physiologic) change in circulating atrial natriuretic factor is required to significantly decrease cardiac output, cardiac filling pressure, and plasma renin activity than is required to significantly increase sodium excretion; and 4) a decrease in systemic atrial pressure and vascular resistance does not occur at physiologic concentrations of atrial natriuretic factor.

AB - Infusion of α-human-atrial natriuretic factor (α-h-ANF) into pentobarbitol anesthesized dogs (n = 10) at 0.0025, 0.005, 0.01, and 0.3 μg/kg/min was performed to differentiate the physiologic actions of atrial natriuretic factor from its pharmacologic actions. The lowest doses of atrial natriuretic factor infusion resulted in circulating levels that were previously produced by 0-10% saline volume expansion. At the lowest infusion rate, circulating ANF increased 31 ± 3 pg/ml, resulting in a significant increase in absolute sodium excretion, fractional excretion of sodium, and fractional excretion of lithium, and a significant decrease in urine osmolality. A greater change in circulating atrial natriuretic factor (96 ± 12 pg/ml) was required to significantly decrease right atrial pressure, cardiac output, and plasma renin activity, and to increase systemic vascular resistance and total and fractional excretion of potassium. The highest dose of atrial natriuretic factor infused was required to decrease arterial pressure and renal vascular resistance. The present study demonstrates that 1) atrial natriuretic factor is natriuretic and diuretic at physiologic concentrations; 2) at low concentrations, atrial natriuretic factor appears to decrease the whole kidney proximal tubular reabsorption of sodium and does not affect glomerular filtration rate; 3) a greater (but physiologic) change in circulating atrial natriuretic factor is required to significantly decrease cardiac output, cardiac filling pressure, and plasma renin activity than is required to significantly increase sodium excretion; and 4) a decrease in systemic atrial pressure and vascular resistance does not occur at physiologic concentrations of atrial natriuretic factor.

UR - http://www.scopus.com/inward/record.url?scp=0023212902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023212902&partnerID=8YFLogxK

M3 - Article

C2 - 2955951

AN - SCOPUS:0023212902

VL - 61

SP - 63

EP - 69

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 1

ER -